GB9419011D0 - Use of muramyl peptide compounds - Google Patents

Use of muramyl peptide compounds

Info

Publication number
GB9419011D0
GB9419011D0 GB9419011A GB9419011A GB9419011D0 GB 9419011 D0 GB9419011 D0 GB 9419011D0 GB 9419011 A GB9419011 A GB 9419011A GB 9419011 A GB9419011 A GB 9419011A GB 9419011 D0 GB9419011 D0 GB 9419011D0
Authority
GB
United Kingdom
Prior art keywords
peptide compounds
muramyl peptide
muramyl
compounds
peptide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GB9419011A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Peptech UK Ltd
Original Assignee
Peptech UK Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Peptech UK Ltd filed Critical Peptech UK Ltd
Priority to GB9419011A priority Critical patent/GB9419011D0/en
Publication of GB9419011D0 publication Critical patent/GB9419011D0/en
Priority to CA002200570A priority patent/CA2200570A1/en
Priority to SK366-97A priority patent/SK36697A3/en
Priority to KR1019970701823A priority patent/KR970706015A/en
Priority to CZ97861A priority patent/CZ86197A3/en
Priority to PCT/GB1995/002237 priority patent/WO1996009063A1/en
Priority to EP95932084A priority patent/EP0782454A1/en
Priority to JP8510688A priority patent/JPH10506387A/en
Priority to AU35274/95A priority patent/AU3527495A/en
Priority to HU9800756A priority patent/HUT77741A/en
Priority to ZA957997A priority patent/ZA957997B/en
Priority to IL11539195A priority patent/IL115391A0/en
Priority to BG101325A priority patent/BG101325A/en
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/14Peptides containing saccharide radicals; Derivatives thereof, e.g. bleomycin, phleomycin, muramylpeptides or vancomycin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/20Antivirals for DNA viruses
    • A61P31/22Antivirals for DNA viruses for herpes viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
GB9419011A 1994-09-21 1994-09-21 Use of muramyl peptide compounds Pending GB9419011D0 (en)

Priority Applications (13)

Application Number Priority Date Filing Date Title
GB9419011A GB9419011D0 (en) 1994-09-21 1994-09-21 Use of muramyl peptide compounds
HU9800756A HUT77741A (en) 1994-09-21 1995-09-20 Use of muramyl peptide compounds
EP95932084A EP0782454A1 (en) 1994-09-21 1995-09-20 Use of muramyl peptide compounds
SK366-97A SK36697A3 (en) 1994-09-21 1995-09-20 Use of muramyl peptide compounds
KR1019970701823A KR970706015A (en) 1994-09-21 1995-09-20 Use of Muramyl Peptide Compounds
CZ97861A CZ86197A3 (en) 1994-09-21 1995-09-20 Use of muramyl peptide compounds
PCT/GB1995/002237 WO1996009063A1 (en) 1994-09-21 1995-09-20 Use of muramyl peptide compounds
CA002200570A CA2200570A1 (en) 1994-09-21 1995-09-20 Use of muramyl peptide compounds
JP8510688A JPH10506387A (en) 1994-09-21 1995-09-20 Use of muramyl peptide compounds
AU35274/95A AU3527495A (en) 1994-09-21 1995-09-20 Use of muramyl peptide compounds
ZA957997A ZA957997B (en) 1994-09-21 1995-09-21 Use of muramyl peptide compounds
IL11539195A IL115391A0 (en) 1994-09-21 1995-09-21 Use of muramyl peptide compounds
BG101325A BG101325A (en) 1994-09-21 1997-03-13 Use of muramyl peptide compounds

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB9419011A GB9419011D0 (en) 1994-09-21 1994-09-21 Use of muramyl peptide compounds

Publications (1)

Publication Number Publication Date
GB9419011D0 true GB9419011D0 (en) 1994-11-09

Family

ID=10761674

Family Applications (1)

Application Number Title Priority Date Filing Date
GB9419011A Pending GB9419011D0 (en) 1994-09-21 1994-09-21 Use of muramyl peptide compounds

Country Status (13)

Country Link
EP (1) EP0782454A1 (en)
JP (1) JPH10506387A (en)
KR (1) KR970706015A (en)
AU (1) AU3527495A (en)
BG (1) BG101325A (en)
CA (1) CA2200570A1 (en)
CZ (1) CZ86197A3 (en)
GB (1) GB9419011D0 (en)
HU (1) HUT77741A (en)
IL (1) IL115391A0 (en)
SK (1) SK36697A3 (en)
WO (1) WO1996009063A1 (en)
ZA (1) ZA957997B (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997005890A1 (en) * 1995-08-08 1997-02-20 Allergan Method of increasing tear production by topical administration of muramyl peptide
DE10106852A1 (en) * 2001-02-14 2002-09-05 T Luger Anti-inflammatory compounds
CN108785251B (en) * 2018-01-23 2020-11-24 盛元医药广州有限公司 Medicinal composition for eyes and preparation method and application thereof
CN117355298A (en) 2021-03-19 2024-01-05 生物治疗探索股份有限公司 Compounds for modulating training immunity and methods of use thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3070457D1 (en) * 1979-10-02 1985-05-15 Ciba Geigy Ag Combinatory compositions for use in a method for enhancing the activity of antibiotics, antibiotic preparations having enhanced activity and process for their production
EP0056560A1 (en) * 1981-01-19 1982-07-28 Ciba-Geigy Ag Active antibiotic compositions, process for their manufacture and process for the antibiotic activity of antibiotics
EP0102319B1 (en) * 1982-07-23 1987-08-19 Ciba-Geigy Ag Prophylactic and therapeutic use of muramyl peptides and their analogues against viral infections
JPH04506808A (en) * 1989-07-19 1992-11-26 ジ・アップジョン・カンパニー Peptides containing diaminoglycols as transition state mimics
JP3628689B2 (en) * 1991-11-19 2005-03-16 ペプテック(ユーケイ)リミティド Muramyl compounds for the treatment of septic shock
US5679348A (en) * 1992-02-03 1997-10-21 Cedars-Sinai Medical Center Immunotherapy for recurrent HSV infections
MX9301789A (en) * 1992-04-03 1993-10-01 Iaf Biochem Int NEW LIPOPHILIC OLIGOPEPTIDES WITH IMMUNOMODULATING ACTIVITY.

Also Published As

Publication number Publication date
BG101325A (en) 1998-01-30
CA2200570A1 (en) 1996-03-28
KR970706015A (en) 1997-11-03
CZ86197A3 (en) 1997-08-13
WO1996009063A1 (en) 1996-03-28
EP0782454A1 (en) 1997-07-09
JPH10506387A (en) 1998-06-23
AU3527495A (en) 1996-04-09
ZA957997B (en) 1997-03-24
SK36697A3 (en) 1997-11-05
HUT77741A (en) 1998-07-28
IL115391A0 (en) 1995-12-31

Similar Documents

Publication Publication Date Title
GB9421709D0 (en) Therapeutic compounds
CY2249B1 (en) Therapeutic compounds
GB9526560D0 (en) Use of 2-Amino-Heterocycles
IL113248A0 (en) Use of alpha - 1c specific compounds
EP0752873A4 (en) Labelled peptide compounds
IL114542A0 (en) Use of muramyl peptide compounds
GB9418762D0 (en) Use of substituted cyclopentane-DI-and-triones
ZA959517B (en) Leutherobin and analogs thereof
IL113992A0 (en) Use of copolymer-1
SG42329A1 (en) Use of phenylcyclohexylcarboxamides
IL115391A0 (en) Use of muramyl peptide compounds
GB9506372D0 (en) New peptide compounds
GB9413751D0 (en) Immunodominant peptides
ZA978027B (en) The use of muramyl peptides
GB9411594D0 (en) Demagnetisation of materials
NZ295530A (en) Preparation of 1-halo-3-trialkylsilanyl-benzenes
GB9422764D0 (en) Use of compound
ZA9510201B (en) New peptide compounds
IL118225A0 (en) Use of felodipine
GB9418295D0 (en) Preparation of indoloquinone compounds
GB9722026D0 (en) Use of compounds
GB9414971D0 (en) Preparation of thionucleosides
HU9403029D0 (en) Praess for preparation of n-methoxy-acetyl-anilines
GB9504891D0 (en) New peptide compounds
GB9510042D0 (en) New peptide compounds